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Abstract
In this commentary, I argue that corruption in health systems is a critical and legitimate area for research in order 
to strengthen health policy goals.  This rationale is based partly on citizen demand for more accountable and 
transparent health systems, along with the fact that the poor and vulnerable suffer the most from the presence 
of corruption in health systems. What is more, there is a growing body of literature on the impact of corruption 
in the health system and best practices in terms of anti-corruption, transparency and accountability (ACTA) 
strategies and tactics within the health system. Still, we need to support ACTA integration into the health system 
by having a common definition of corruption that is meaningful for health systems and ensure that ACTA 
strategies and tactics are transparent themselves. The 2019 Consultation on a proposed Global Network on 
ACTA in Health Systems is promising for these efforts.
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In his concurring opinion in Jacobellis v. Ohio (1964), then United States Supreme Court Justice, Potter Stewart, stated “I know it when I see it” with regards to what is hard core 
pornography. When identifying corruption, there is often the 
risk of adopting the same nebulous approach, as corruption 
is often not well defined, or may have different meanings 
depending on the cultural and institutional context.1 In their 
commentary on “We Need to Talk About Corruption in Health 
Systems” Hutchinson et al2 identify and explain five leading 
reasons why corruption in health systems has not been 
confronted well. In this commentary, I examine each of them.
First, the authors importantly identify key barriers to 
eradicating corruption from health systems. Corruption 
in health systems potentially can undercut national public 
health goals, as well as global health goals, such as Sustainable 
Development Goal (SDG) #3: Good Health and Well-Being.3 
As Mackey et al4 have argued, combating corruption should 
be a core value of the SDGs, given its linkages with human 
rights, equity, economic development and Universal Health 
Coverage (p. 640). 
The authors underscore that we need to initiate (what 
I assume is) a public policy-driven conversation about 
corruption in health system. This conversation is happening. 
To provide some context, as far back as 1996, then World 
Bank President James D. Wolfensohn expressed that a 
‘cancer of corruption’ was depleting resources from the 
world’s poor in his speech at the Annual Joint Meeting of 
the International Monetary Fund and the World Bank.5 
Wolfensohn’s high profile speech helped initiate a growing 
exploration of the impact of corruption in development 
financing and operations, including the health sector.6-8
The health system is indeed a rich place for the study 
of corruption. As a result of its fragmentation, technical 
complexity, and the vast sums of money involved in the 
purchase of health products and its operations, it is an 
optimal space for corruption to thrive. Corruption is found 
throughout the health system; from petty corruption at 
the health facility level to corruption that takes place at the 
highest level of the state.8 
There is indeed a growing body of evidence which is 
documenting the pernicious effect corruption has had on 
health systems, particularly in terms of health equity goals. For 
instance, Vian’s research on corruption and its consequences 
for public health, the European Commission’s Study on 
Corruption in the Healthcare Sector, and Transparency 
International’s recent study on corruption risks in health 
system delivery.9-11 Transparency International has in fact 
focused its policy work on corruption in the health sector as 
far back as in 2006 as documented in its annual publication, 
The Global Corruption Report.12 
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A number of United Nations organizations, including 
the World Bank, the World Health Organization (WHO), 
the Global Fund, and the United Nations Development 
Programme (UNDP) have also addressed corruption through 
their institutional policy and country operational work. Still, 
anti-corruption efforts by international organizations have 
regularly been obfuscated by more benign concepts, such 
as good governance, risk management, and health systems 
strengthening.13-15 Anti-corruption, transparency and 
accountability (ACTA) efforts, surely need to be identified 
as such in order to make progress towards the reduction of 
corruption in the health system. Hutchinson et al illuminate 
other key barriers; I examine each in the below. 
Reason 1: it is difficult to define corruption.
How do we define corruption? It is undeniably a thorny 
enterprise to arrive at a single definition of corruption 
given its complexity and reach. Hutchinson et al point out 
that corruption in its many forms may not be considered 
as such uniformly, and they provide examples of why this 
is the case. What is corruption (and here I am limiting it to 
its manifestations in the healthcare system) may very much 
depend on its health systems institutional context and cultural 
setting. Certainly, gifts to physicians in some countries may 
be considered as “gratitude payments.”16-22 This may not be 
viewed as corruption per se but as a culturally acceptable 
practice – often related to the poor salaries that health 
professionals receive.23-26 
But here is where we must draw a line; we need to stop 
making allowances for the vast smorgasbord of definitions 
that populate the field. Hutchinson et al emphasize that it 
is difficult to define corruption. For this reason, we need 
a common definition that translates easily into practice 
and across geographical, social, institutional and cultural 
terrain and is relevant for the health system. Transparency 
International has an expansive definition of corruption that 
could serve as the common definition. It is  “Corruption is the 
abuse of entrusted power for private gain. It can be classified 
as grand, petty and political, depending on the amounts of 
money lost and the sector where it occurs.”27 The adoption of 
a common definition of corruption, such as the one proposed, 
which is meaningful for the health system, could potentially 
be advanced within a global health forum, such as the World 
Health Assembly.
Reason Two: Practices that seem corrupt may actually be 
seen by those concerned, both providers of services and their 
beneficiaries, as the only means of enabling some fragile 
health systems simply to keep working. 
To be sure, informal payments to health professionals may be 
viewed as vital for the functioning of a poorly resourced public 
healthcare system,28 and cultural factors.24,29-31 For instance, 
Cockcroft et al,32 in their study of unofficial payments in 
the health sector of Baltic states, found that the majority of 
the patients they surveyed – nearly 50% – did not consider 
unofficial payments to health workers as corruption. While 
informal payments may help healthcare services in some 
cases, they are undeniably potential barriers to healthcare 
services for the poor and vulnerable. Accordingly, we need 
to stop making allowances for corruption, even when it may 
result in socially desirable results.
Reason Three: How do we conduct research on corruption in 
ways that capture what is really happening?
Researching corruption, whether it is in the health system, 
or elsewhere, is challenging given that corruption tends to 
be hidden. Very often stakeholders are reluctant to speak 
about corruption openly; they may be committing corrupt 
acts themselves or fear reprisals by those who are committing 
it. Hutchinson et al underscore that research efforts may not 
capture the truth of corruption and that researchers face the 
moral quandary of seeking access to those who may very well 
be engaged in exploitative behaviour in order to report it. 
These concerns are certainly valid. Still, researchers are doing 
a vital part in anti-corruption efforts by seeking to identify the 
how, why, and what of corruption in the health system even 
when research relies on perceptions.33 And while research 
may not illuminate the full story of how corruption is taking 
place and detail the granularity of its impact, even exploratory 
research is absolutely fundamental to grasping what strategies 
and tactics will work most effectively to reduce the risk of 
corruption in health systems. 
Reason Four: Is it even legitimate to study corruption?
Citizen demand for more accountable and transparent health 
systems has in fact helped promote more policy attention to 
corruption generally and in health systems. What is certain 
is that evidence-based research can help promote sound 
public policy. Corruption within the health system harms 
the poor and most vulnerable population groups the most.34 
For instance, a 2015 study by Transparency International on 
corruption in Africa reported that the poor are often forced 
to pay bribes for access to “free” public services.35 When 
considering the need for governments to respond to citizen 
demands and the impact of corruption in the health system 
on the poor and vulnerable, it is indeed a valuable enterprise 
to study corruption.
Reason Five: We know too little about how to tackle corruption. 
Hutchinson et al cite a recent Cochrane review that did not 
find any studies with empirical evidence concerning the 
effects of strategies to reduce corruption. What is more, the 
review found that only a small number of the studies could 
be used to inform further evaluations.36 Still, there is an ever 
growing body of literature that is examining the effect of 
ACTA measures that is informative and often helpful in terms 
of identifying best practices.37 While we need to know more 
about what are the optimal strategies and tactics to tackle 
corruption, we are certainly gaining knowledge about what 
works well and where.
And as a final consideration, what do we do about 
corruption in the health sector? The authors recommend 
convening stakeholders in the health system that can then 
speak openly about corruption and reach agreement on 
realistic priority areas and actions. This has recently come to 
fruition: the WHO, UNDP, and the Global Fund in February 
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2019 in Geneva convened a multi-stakeholder consultation 
on a proposed Global Network on ACTA in Health Systems.38 
This Consultation convened over one hundred policy-
makers, researchers, non-governmental organizations, 
government officials and representatives from United Nations 
organizations to discuss corruption in the health system. 
The Consultation concluded with a proposed workplan for 
the Network. It included outputs such as: (1) rationalizing 
internal control and assurance models in health systems 
using fraud and corruption risk assessment methodologies; 
(2) monitoring and evaluation of ACTA measures for health; 
(3) capacity development on ACTA in the health sector for 
multiple stakeholders; and (4) the integration of ACTA into 
health systems strengthening normative guidance.
In conclusion, it is helpful to consider what are the potential 
barriers to addressing corruption in health systems as this can 
assist researchers and policy-makers to overcome them. ACTA 
work clearly needs to be more fully integrated into health 
system policy and practice. For certain, global initiatives are 
underway and progress in the fight against corruption in 
the health system appear promising. “Corruption is deeply 
embedded in social, political and economic dynamics, 
and cannot be isolated from them because of its many 
interconnected causes and effects.”39 Given this inherent 
complexity, we need to learn more about how to address 
corruption in health systems. For this, we need to continue 
the conversation about corruption and determine how to best 
overcome the barriers Hutchinson et al advance.
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